Bladder Bank (a Prospective Banking Study)
ConditionBladder Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Eligibility criteria
Qualifiers
Age > 18 years
Patient has undergone office-based evaluation for hematuria [computed tomography (CT), ultrasound, cystoscopy]
Disqualifiers
Patient has known cancer outside of the target cancer 5 years prior to current collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible)
Patient has recurrent muscle invasive bladder cancer
Patient has ever been previously diagnosed with UTUC (upper tract urothelial carcinoma) prior to bladder resection
Patient has received chemotherapy class drugs for the treatment of non-target origin cancer in the 5 years prior to current collection
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
1,500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov